IL6 and breast cancer: In accordance with the critical roles of chronic inflammation and immune cells in causing changes in microenvironment during tumorigenesis, IL-6 signaling is required for CSC maintenance in glioma [96,97], lung [98], colon [99], and breast cancer [100,101,102].